Skip to content
Home/Companies/MedTech/Antelliq
AN

Antelliq

MedTech·France·Exited 2019·Held 6yr

Antelliq is a TMT company, headquartered in France.

Entry
2013
Hold
6yr
Exit
2019
Est. EV
–

Who owns Antelliq?

Antelliq was owned by BC Partners through BC European Capital IX (2012 vintage) from 2013 to 2019, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

BC Partners
Investor
BC Partners
BC European Capital IX · 2012 · Buyout

Key facts

HQFrance
SectorTMT
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2019

More from BC European Capital IX

Other portfolio companies in the same fund.

Cigierre
Active
ConsumerItaly· 2015
Pharmathen
Exited 2021
PharmaGreece· 2015
to
Acuris
Exited 2019
Business ServicesUK· 2014
to
Springer Nature
Exited 2024
TMTGermany· 2013
Aenova
Exited 2024
PharmaGermany· 2012
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings